Public-registry site landscape for NCT05934253, a Antiseptic study sponsored by Harrow Inc. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05934253 (registry record) |
| Sponsor | Harrow Inc |
| Condition(s) | Antiseptic; Anesthesia, Local |
| Phase | PHASE4 |
| Listed sites | 1 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05934253 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →